|
KIF15 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.63289999802296E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.29220000000208E-05 |
| Normal-vs-Stage2 |
2.764000E-03 |
| Normal-vs-Stage3 |
2.02689999999617E-05 |
| Normal-vs-Stage4 |
1.8986700000001E-05 |
| Stage1-vs-Stage2 |
3.535600E-01 |
| Stage1-vs-Stage3 |
2.704000E-02 |
| Stage1-vs-Stage4 |
6.559300E-04 |
| Stage2-vs-Stage3 |
4.226400E-01 |
| Stage2-vs-Stage4 |
4.203800E-03 |
| Stage3-vs-Stage4 |
1.170200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.32419999912636E-08 |
| Normal-vs-AfricanAmerican |
6.857900E-03 |
| Normal-vs-Asian |
1.668560E-01 |
| Caucasian-vs-AfricanAmerican |
2.515700E-02 |
| Caucasian-vs-Asian |
4.589200E-01 |
| AfricanAmerican-vs-Asian |
3.472000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.67970000025863E-08 |
| Normal-vs-Female |
4.10320000000519E-05 |
| Male-vs-Female |
3.438100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.799000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.01190000004292E-06 |
| Normal-vs-Age(61-80Yrs) |
1.68639999997833E-06 |
| Normal-vs-Age(81-100Yrs) |
6.272500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.858000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.852200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.111600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.369000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.839600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.772300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.814770E-01 |
| Normal-vs-Grade 2 |
5.60250000000151E-05 |
| Normal-vs-Grade 3 |
1.05530000005238E-06 |
| Normal-vs-Grade 4 |
2.27179999999771E-05 |
| Grade 1-vs-Grade 2 |
8.438600E-03 |
| Grade 1-vs-Grade 3 |
1.007270E-04 |
| Grade 1-vs-Grade 4 |
9.76329999999859E-05 |
| Grade 2-vs-Grade 3 |
2.838000E-02 |
| Grade 2-vs-Grade 4 |
6.975000E-04 |
| Grade 3-vs-Grade 4 |
3.798900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.797790E-03 |
| Normal-vs-ccB subtype |
1.04099999997942E-06 |
| ccA subtype-vs-ccB subtype |
6.784200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.15830000000517E-07 |
| Normal-vs-N1 |
1.455460E-03 |
| N0-vs-N1 |
2.622500E-03 |
|
|
